HER2 Support Group Forums
>
Articles of Interest
All Relevant Subgroups With ESR1-Mutant MBC Derive PFS Benefit With Elacestrant
User Name
Remember Me?
Password
Register
Gallery
FAQ
Members List
Calendar
Search
Today's Posts
Mark Forums Read
Thread Tools
Display Modes
12-10-2023, 05:49 PM
#
1
Nguyen
Senior Member
Join Date: Nov 2005
Posts: 531
All Relevant Subgroups With ESR1-Mutant MBC Derive PFS Benefit With Elacestrant
All Relevant Subgroups With ESR1-Mutant MBC Derive PFS Benefit With Elacestrant
https://www.oncnursingnews.com/view/...th-elacestrant
"...In patients with HER2-low expression, median PFS was 9.03 months vs 1.87 months, respectively (HR, 0.301; 95% CI, 0.142-0.604)..."
Nguyen
View Public Profile
Send a private message to Nguyen
Find More Posts by Nguyen
«
Previous Thread
|
Next Thread
»
Thread Tools
Show Printable Version
Email this Page
Display Modes
Linear Mode
Switch to Hybrid Mode
Switch to Threaded Mode
Posting Rules
You
may not
post new threads
You
may not
post replies
You
may not
post attachments
You
may not
edit your posts
BB code
is
On
Smilies
are
On
[IMG]
code is
On
HTML code is
On
Forum Rules
Forum Jump
User Control Panel
Private Messages
Subscriptions
Who's Online
Search Forums
Forums Home
her2group
Herceptin / Tykerb
Caregivers Corner
Diet and Nutrition
Inflammatory Breast Cancer
Keeping Your Mind Off of BC
Profiles In Courage
My Healthcare Team
Clinical Trials
Articles of Interest
Events and Social Calendar
Breast Cancer Meeting Highlights
General Cancer News
Breast Cancer News
Breast Cancer Newsfeed
All times are GMT -7. The time now is
10:15 PM
.
Linear Mode
